{"id":14767,"date":"2017-02-04T02:44:57","date_gmt":"2017-02-04T07:44:57","guid":{"rendered":"http:\/\/goldstocksforex.com\/?p=14767"},"modified":"2017-02-04T02:44:57","modified_gmt":"2017-02-04T07:44:57","slug":"sp-500-price-earnings-suggest-time-to-buy","status":"publish","type":"post","link":"https:\/\/thepatientinvestor.com\/index.php\/2017\/02\/04\/sp-500-price-earnings-suggest-time-to-buy\/","title":{"rendered":"S&#038;P 500 Price-Earnings suggest time to buy"},"content":{"rendered":"<p>The forward Price-Earnings (PE) Ratio for the S&amp;P 500, depicted by the blue line on the chart below, recently dipped below 20. In 2014 to 2105, PEs above 20 warned that stocks were overpriced.<\/p>\n<p>We can see from the green and orange bars on the chart that the primary reason for the dip in forward PE is more optimistic earnings forecasts for 2017.<\/p>\n<p><img data-recalc-dims=\"1\" decoding=\"async\" class=\"aligncenter\" title=\"S&amp;P500 Earnings Per Share and Forward PE Ratio\" alt=\"S&amp;P500 Earnings Per Share and Forward PE Ratio\" src=\"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2017\/2017-02-04-spx-forwardpe.png?w=525&#038;ssl=1\" \/><\/p>\n<p>We can also see, from an examination of the past history, that each time forward PE dipped below 20 it was an opportune time to buy.<\/p>\n<p>History also shows that each time the forward PE crossed to above 20 it was an opportune time to stop buying. Not necessarily a sell signal but a warning to investors to tighten their stops.<\/p>\n<h3>Sector Performance<\/h3>\n<p>Quarterly sales figures are only available to June 2016 but there are two stand-out sectors that achieved quarterly year-on-year sales growth in excess of 10 percent: Consumer Discretionary and Health Care.<\/p>\n<p><img data-recalc-dims=\"1\" decoding=\"async\" class=\"aligncenter\" title=\"S&amp;P500 Quarterly Sales Growth\" alt=\"S&amp;P500 Quarterly Sales Growth\" src=\"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2017\/2017-02-04-spx-sales.png?w=525&#038;ssl=1\" \/><\/p>\n<p>Interestingly, apart from Energy where there has been a sharp drop in earnings, sectors with the highest forward PE (based on estimated operating earnings) are the defensive sectors: Consumer Staples and Utilities. While Consumer Discretionary and Health Care are more middle-of-the-pack at 16.7 and 15.4 respectively.<\/p>\n<p><img data-recalc-dims=\"1\" decoding=\"async\" class=\"aligncenter\" title=\"S&amp;P500 Forward PE Ratio by Sector\" alt=\"S&amp;P500 Forward PE Ratio by Sector\" src=\"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2017\/2017-02-04-spx-sectorpe.png?w=525&#038;ssl=1\" \/><\/p>\n<p><!--End--><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The forward Price-Earnings (PE) Ratio for the S&amp;P 500, depicted by the blue line on the chart below, recently dipped below 20. In 2014 to 2105, PEs above 20 warned that stocks were overpriced. We can see from the green and orange bars on the chart that the primary reason for the dip in forward &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/thepatientinvestor.com\/index.php\/2017\/02\/04\/sp-500-price-earnings-suggest-time-to-buy\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;S&#038;P 500 Price-Earnings suggest time to buy&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_mo_disable_npp":"","_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[48,57,34],"tags":[1154,1448,2626,3010,3026,3061],"class_list":["post-14767","post","type-post","status-publish","format-standard","hentry","category-earnings-dividends","category-stock-markets","category-us-canada-countries-regions","tag-earnings","tag-forward-price-earnings","tag-pe-ratio","tag-sp-500","tag-sales","tag-sectors"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>S&amp;P 500 Price-Earnings suggest time to buy - the patient investor<\/title>\n<meta name=\"robots\" content=\"noindex, follow\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"S&amp;P 500 Price-Earnings suggest time to buy - the patient investor\" \/>\n<meta property=\"og:description\" content=\"The forward Price-Earnings (PE) Ratio for the S&amp;P 500, depicted by the blue line on the chart below, recently dipped below 20. In 2014 to 2105, PEs above 20 warned that stocks were overpriced. We can see from the green and orange bars on the chart that the primary reason for the dip in forward &hellip; Continue reading &quot;S&#038;P 500 Price-Earnings suggest time to buy&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/thepatientinvestor.com\/index.php\/2017\/02\/04\/sp-500-price-earnings-suggest-time-to-buy\/\" \/>\n<meta property=\"og:site_name\" content=\"the patient investor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61572934660810\" \/>\n<meta property=\"article:published_time\" content=\"2017-02-04T07:44:57+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/static.incrediblecharts.com\/images\/2017\/2017-02-04-spx-forwardpe.png\" \/>\n<meta name=\"author\" content=\"ColinTwiggs\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"ColinTwiggs\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2017\\\/02\\\/04\\\/sp-500-price-earnings-suggest-time-to-buy\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2017\\\/02\\\/04\\\/sp-500-price-earnings-suggest-time-to-buy\\\/\"},\"author\":{\"name\":\"ColinTwiggs\",\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/#\\\/schema\\\/person\\\/cb072791ac83e8bae585007c133d54a5\"},\"headline\":\"S&#038;P 500 Price-Earnings suggest time to buy\",\"datePublished\":\"2017-02-04T07:44:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2017\\\/02\\\/04\\\/sp-500-price-earnings-suggest-time-to-buy\\\/\"},\"wordCount\":200,\"commentCount\":13,\"publisher\":{\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2017\\\/02\\\/04\\\/sp-500-price-earnings-suggest-time-to-buy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.incrediblecharts.com\\\/images\\\/2017\\\/2017-02-04-spx-forwardpe.png\",\"keywords\":[\"earnings\",\"Forward Price-Earnings\",\"PE ratio\",\"S&amp;P 500\",\"sales\",\"Sectors\"],\"articleSection\":[\"Earnings &amp; Dividends\",\"Stock Markets\",\"US &amp; Canada\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2017\\\/02\\\/04\\\/sp-500-price-earnings-suggest-time-to-buy\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2017\\\/02\\\/04\\\/sp-500-price-earnings-suggest-time-to-buy\\\/\",\"url\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2017\\\/02\\\/04\\\/sp-500-price-earnings-suggest-time-to-buy\\\/\",\"name\":\"S&P 500 Price-Earnings suggest time to buy - the patient investor\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2017\\\/02\\\/04\\\/sp-500-price-earnings-suggest-time-to-buy\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2017\\\/02\\\/04\\\/sp-500-price-earnings-suggest-time-to-buy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.incrediblecharts.com\\\/images\\\/2017\\\/2017-02-04-spx-forwardpe.png\",\"datePublished\":\"2017-02-04T07:44:57+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2017\\\/02\\\/04\\\/sp-500-price-earnings-suggest-time-to-buy\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2017\\\/02\\\/04\\\/sp-500-price-earnings-suggest-time-to-buy\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2017\\\/02\\\/04\\\/sp-500-price-earnings-suggest-time-to-buy\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.incrediblecharts.com\\\/images\\\/2017\\\/2017-02-04-spx-forwardpe.png\",\"contentUrl\":\"https:\\\/\\\/www.incrediblecharts.com\\\/images\\\/2017\\\/2017-02-04-spx-forwardpe.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2017\\\/02\\\/04\\\/sp-500-price-earnings-suggest-time-to-buy\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/thepatientinvestor.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"S&#038;P 500 Price-Earnings suggest time to buy\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/#website\",\"url\":\"https:\\\/\\\/thepatientinvestor.com\\\/\",\"name\":\"The Patient Investor\",\"description\":\"Smart. Strategic. Unfiltered. \",\"publisher\":{\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/thepatientinvestor.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/#organization\",\"name\":\"The Patient Investor Pty Ltd\",\"url\":\"https:\\\/\\\/thepatientinvestor.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/i0.wp.com\\\/thepatientinvestor.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1\",\"contentUrl\":\"https:\\\/\\\/i0.wp.com\\\/thepatientinvestor.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1\",\"width\":250,\"height\":250,\"caption\":\"The Patient Investor Pty Ltd\"},\"image\":{\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61572934660810\",\"https:\\\/\\\/www.instagram.com\\\/colin_thepatientinvestor\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/#\\\/schema\\\/person\\\/cb072791ac83e8bae585007c133d54a5\",\"name\":\"ColinTwiggs\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/876c4d990bb2af282291d5f3ff81533c6deccc0c607846086647ca3272fac0ca?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/876c4d990bb2af282291d5f3ff81533c6deccc0c607846086647ca3272fac0ca?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/876c4d990bb2af282291d5f3ff81533c6deccc0c607846086647ca3272fac0ca?s=96&d=mm&r=g\",\"caption\":\"ColinTwiggs\"},\"url\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/author\\\/colin58s\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"S&P 500 Price-Earnings suggest time to buy - the patient investor","robots":{"index":"noindex","follow":"follow"},"og_locale":"en_US","og_type":"article","og_title":"S&P 500 Price-Earnings suggest time to buy - the patient investor","og_description":"The forward Price-Earnings (PE) Ratio for the S&amp;P 500, depicted by the blue line on the chart below, recently dipped below 20. In 2014 to 2105, PEs above 20 warned that stocks were overpriced. We can see from the green and orange bars on the chart that the primary reason for the dip in forward &hellip; Continue reading \"S&#038;P 500 Price-Earnings suggest time to buy\"","og_url":"https:\/\/thepatientinvestor.com\/index.php\/2017\/02\/04\/sp-500-price-earnings-suggest-time-to-buy\/","og_site_name":"the patient investor","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61572934660810","article_published_time":"2017-02-04T07:44:57+00:00","og_image":[{"url":"http:\/\/static.incrediblecharts.com\/images\/2017\/2017-02-04-spx-forwardpe.png","type":"","width":"","height":""}],"author":"ColinTwiggs","twitter_card":"summary_large_image","twitter_misc":{"Written by":"ColinTwiggs","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/thepatientinvestor.com\/index.php\/2017\/02\/04\/sp-500-price-earnings-suggest-time-to-buy\/#article","isPartOf":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2017\/02\/04\/sp-500-price-earnings-suggest-time-to-buy\/"},"author":{"name":"ColinTwiggs","@id":"https:\/\/thepatientinvestor.com\/#\/schema\/person\/cb072791ac83e8bae585007c133d54a5"},"headline":"S&#038;P 500 Price-Earnings suggest time to buy","datePublished":"2017-02-04T07:44:57+00:00","mainEntityOfPage":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2017\/02\/04\/sp-500-price-earnings-suggest-time-to-buy\/"},"wordCount":200,"commentCount":13,"publisher":{"@id":"https:\/\/thepatientinvestor.com\/#organization"},"image":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2017\/02\/04\/sp-500-price-earnings-suggest-time-to-buy\/#primaryimage"},"thumbnailUrl":"https:\/\/www.incrediblecharts.com\/images\/2017\/2017-02-04-spx-forwardpe.png","keywords":["earnings","Forward Price-Earnings","PE ratio","S&amp;P 500","sales","Sectors"],"articleSection":["Earnings &amp; Dividends","Stock Markets","US &amp; Canada"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/thepatientinvestor.com\/index.php\/2017\/02\/04\/sp-500-price-earnings-suggest-time-to-buy\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/thepatientinvestor.com\/index.php\/2017\/02\/04\/sp-500-price-earnings-suggest-time-to-buy\/","url":"https:\/\/thepatientinvestor.com\/index.php\/2017\/02\/04\/sp-500-price-earnings-suggest-time-to-buy\/","name":"S&P 500 Price-Earnings suggest time to buy - the patient investor","isPartOf":{"@id":"https:\/\/thepatientinvestor.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2017\/02\/04\/sp-500-price-earnings-suggest-time-to-buy\/#primaryimage"},"image":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2017\/02\/04\/sp-500-price-earnings-suggest-time-to-buy\/#primaryimage"},"thumbnailUrl":"https:\/\/www.incrediblecharts.com\/images\/2017\/2017-02-04-spx-forwardpe.png","datePublished":"2017-02-04T07:44:57+00:00","breadcrumb":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2017\/02\/04\/sp-500-price-earnings-suggest-time-to-buy\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/thepatientinvestor.com\/index.php\/2017\/02\/04\/sp-500-price-earnings-suggest-time-to-buy\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/thepatientinvestor.com\/index.php\/2017\/02\/04\/sp-500-price-earnings-suggest-time-to-buy\/#primaryimage","url":"https:\/\/www.incrediblecharts.com\/images\/2017\/2017-02-04-spx-forwardpe.png","contentUrl":"https:\/\/www.incrediblecharts.com\/images\/2017\/2017-02-04-spx-forwardpe.png"},{"@type":"BreadcrumbList","@id":"https:\/\/thepatientinvestor.com\/index.php\/2017\/02\/04\/sp-500-price-earnings-suggest-time-to-buy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/thepatientinvestor.com\/"},{"@type":"ListItem","position":2,"name":"S&#038;P 500 Price-Earnings suggest time to buy"}]},{"@type":"WebSite","@id":"https:\/\/thepatientinvestor.com\/#website","url":"https:\/\/thepatientinvestor.com\/","name":"The Patient Investor","description":"Smart. Strategic. Unfiltered. ","publisher":{"@id":"https:\/\/thepatientinvestor.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/thepatientinvestor.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/thepatientinvestor.com\/#organization","name":"The Patient Investor Pty Ltd","url":"https:\/\/thepatientinvestor.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/thepatientinvestor.com\/#\/schema\/logo\/image\/","url":"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2026\/03\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1","contentUrl":"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2026\/03\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1","width":250,"height":250,"caption":"The Patient Investor Pty Ltd"},"image":{"@id":"https:\/\/thepatientinvestor.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61572934660810","https:\/\/www.instagram.com\/colin_thepatientinvestor"]},{"@type":"Person","@id":"https:\/\/thepatientinvestor.com\/#\/schema\/person\/cb072791ac83e8bae585007c133d54a5","name":"ColinTwiggs","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/876c4d990bb2af282291d5f3ff81533c6deccc0c607846086647ca3272fac0ca?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/876c4d990bb2af282291d5f3ff81533c6deccc0c607846086647ca3272fac0ca?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/876c4d990bb2af282291d5f3ff81533c6deccc0c607846086647ca3272fac0ca?s=96&d=mm&r=g","caption":"ColinTwiggs"},"url":"https:\/\/thepatientinvestor.com\/index.php\/author\/colin58s\/"}]}},"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p9tQ4n-3Qb","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":14689,"url":"https:\/\/thepatientinvestor.com\/index.php\/2016\/12\/15\/nasdaq-breaks-its-dotcom-high\/","url_meta":{"origin":14767,"position":0},"title":"Nasdaq breaks its Dotcom high","author":"ColinTwiggs","date":"December 15, 2016","format":false,"excerpt":"Tech-heavy Nasdaq 100 broke through its all-time high at 4900, first reached in the Dotcom bubble of 1999\/2000. Follow-through above 5000 would signal another primary advance. Bearish divergence on 13-week Twiggs Money Flow warns of medium-term selling pressure, possibly profit-taking at the long-term high. The daily chart of the S&P\u2026","rel":"","context":"In &quot;Earnings &amp; Dividends&quot;","block_context":{"text":"Earnings &amp; Dividends","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/investing\/earnings-dividends\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":18217,"url":"https:\/\/thepatientinvestor.com\/index.php\/2019\/05\/17\/is-the-sp-500-way-over-priced\/","url_meta":{"origin":14767,"position":1},"title":"Is the S&#038;P 500 way over-priced?","author":"Colin Twiggs","date":"May 17, 2019","format":false,"excerpt":"Robert Shiller's CAPE (Price\/10-year simple MA of inflation-adjusted earnings) is at 30.31, the second-highest peak (behind the Dotcom bubble) in 120 years. PEmax (Price\/highest prior 12-month earnings) is far lower at 21.04. I prefer this as a more accurate measure of stock pricing than CAPE. But PEmax is still high\u2026","rel":"","context":"In &quot;Stock Markets&quot;","block_context":{"text":"Stock Markets","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/stock-markets\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":14880,"url":"https:\/\/thepatientinvestor.com\/index.php\/2017\/02\/27\/forward-pe-turns-back-up\/","url_meta":{"origin":14767,"position":2},"title":"Forward P\/E turns back up","author":"ColinTwiggs","date":"February 27, 2017","format":false,"excerpt":"Dow Jones Industrials Dow Jones Industrial Average continues to climb, heading for a target of 21000. Rising troughs on Twiggs Money Flow signal strong buying pressure. The S&P 500 follows a similar path. With the CBOE Volatility Index (VIX) close to historic lows around 10 percent. However, at least one\u2026","rel":"","context":"In &quot;Earnings &amp; Dividends&quot;","block_context":{"text":"Earnings &amp; Dividends","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/investing\/earnings-dividends\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":26535,"url":"https:\/\/thepatientinvestor.com\/index.php\/2021\/06\/26\/sp-500-and-the-fed-taper\/","url_meta":{"origin":14767,"position":3},"title":"S&#038;P 500 and the Fed taper","author":"Colin Twiggs","date":"June 26, 2021","format":false,"excerpt":"S&P 500 earnings forecasts show a sizable jump in the March quarter (97.3% reported) followed by a weaker June quarter as the economy struggles with supply chain interruptions and labor shortages. Record operating margins of 13.0% estimated for the first quarter (March '21) are unlikely to be repeated. The average\u2026","rel":"","context":"In &quot;GDP and Activity&quot;","block_context":{"text":"GDP and Activity","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/economy\/gdp-and-activity\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":39540,"url":"https:\/\/thepatientinvestor.com\/index.php\/2022\/12\/14\/have-stock-prices-lost-touch-with-reality\/","url_meta":{"origin":14767,"position":4},"title":"Have stock prices lost touch with reality?","author":"Colin Twiggs","date":"December 14, 2022","format":false,"excerpt":"Robert Shiller's cyclically-adjusted PE (or CAPE) is at a similar level to the 1929 peak before the greatest crash in US history. CAPE uses a 10-year average of inflation-adjusted earnings in order to smooth out fluctuations in earnings. The current reading of 29.2 is almost double the low during the\u2026","rel":"","context":"In &quot;Australia &amp; NZ&quot;","block_context":{"text":"Australia &amp; NZ","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/countries-regions\/australia-nz-countries-regions\/"},"img":{"alt_text":"US Stock Market Capitalization\/GDP","src":"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2022\/2022-12-12-mcap-gdp.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2022\/2022-12-12-mcap-gdp.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2022\/2022-12-12-mcap-gdp.png?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":47941,"url":"https:\/\/thepatientinvestor.com\/index.php\/2024\/01\/31\/sp-500-losing-touch-with-reality\/","url_meta":{"origin":14767,"position":5},"title":"S&#038;P 500 losing touch with reality","author":"Colin Twiggs","date":"January 31, 2024","format":false,"excerpt":"The S&P 500 climbed to a new high after breaking resistance at its January '22 high of 4800. Rising Trend Index troughs warn of strong buying pressure. Pricing seems to be losing touch with reality. The S&P 500 Price-Earnings ratio climbed to 24.2 on December 31st and is forecast to\u2026","rel":"","context":"In &quot;US &amp; Canada&quot;","block_context":{"text":"US &amp; Canada","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/countries-regions\/us-canada-countries-regions\/"},"img":{"alt_text":"S&P 500","src":"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2024\/2024-02-05-spx.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2024\/2024-02-05-spx.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2024\/2024-02-05-spx.png?resize=525%2C300&ssl=1 1.5x"},"classes":[]}],"_links":{"self":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/posts\/14767","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/comments?post=14767"}],"version-history":[{"count":0,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/posts\/14767\/revisions"}],"wp:attachment":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/media?parent=14767"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/categories?post=14767"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/tags?post=14767"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}